Risk of Second Lung Cancer in Patients with Previously Treated Lung Cancer: Analysis of Surveillance, Epidemiology, and End Results (SEER) Data

Journal of Thoracic Oncology

Volumn 13, Issue 1, 2018, Pages 46-53

  Thakur, Manish K ^a   Ruterbusch, Julie J ^a   Schwartz, Ann G ^a   Gadgeel, Shirish M ^a   Beebe Dimmer, Jennifer L ^a   Wozniak, Antoinette J ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Lung cancer; Second primary; SEER; Surveillance

Indexed keywords

ADULT; AGED; ARTICLE; CANCER REGISTRY; CANCER RISK; CANCER STAGING; FEMALE; HUMAN; LUNG ADENOCARCINOMA; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON SMALL CELL LUNG CANCER; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SECOND CANCER; SMALL CELL LUNG CANCER; SQUAMOUS CELL LUNG CARCINOMA; STANDARDIZED INCIDENCE RATIO; ADENOCARCINOMA; FOLLOW UP; INCIDENCE; LUNG TUMOR; MICHIGAN; PROGNOSIS; SQUAMOUS CELL CARCINOMA; YOUNG ADULT;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LUNG NEOPLASMS; MALE; MICHIGAN; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; PROGNOSIS; RETROSPECTIVE STUDIES; SEER PROGRAM; SMALL CELL LUNG CARCINOMA; YOUNG ADULT;

EID: 85034842812     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1016/j.jtho.2017.09.1964     Document Type: Article

References (27)

1. Siegel, R.L., Miller, K.D., Jemal, A., Cancer statistics, 2016. CA Cancer J Clin 66 (2016), 7–30.
2. Johnson, B.E., Second lung cancers in patients after treatment for an initial lung cancer. J Natl Cancer Inst 90 (1998), 1335–1345.
3. Ha, D., Choi, H., Chevalier, C., Zell, K., Wang, X.F., Mazzone, P.J., Survival in patients with metachronous second primary lung cancer. Ann Am Thorac Soc 12 (2015), 79–84.
4. National Lung Screening Trial Research Team, Aberle, D.R., Adams, A.M., et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 365 (2011), 395–409.
5. National Comprehensive Cancer Network. NCCN guidelines in oncology: lung cancer screening. Version 2.2018. https://www.nccn.org/professionals/physician_gls/pdf/lung_screening.pdf. Accessed March 20, 2017.
6. Kawaguchi, T., Matsumura, A., Iuchi, K., et al. Second primary cancers in patients with stage III non-small cell lung cancer successfully treated with chemo-radiotherapy. Jpn J Clin Oncol 36 (2006), 7–11.
7. Rice, D., Kim, H.W., Sabichi, A., et al. The risk of second primary tumors after resection of stage I nonsmall cell lung cancer. Ann Thorac Surg 76 (2003), 1001–1007 [discussion 1007–1008].
8. Adamo, M., Dickie, L., Ruhl, J., SEER Program Coding and Staging Manual. 2015, National Cancer Institute, Bethesda, MD.
9. National Cancer Institute. The multiple primary and histology coding rules, SEER program. https://seer.cancer.gov/tools/mphrules/. Accessed September 11, 2017.
10. Radzikowska, E., Glaz, P., Roszkowski, K., Lung cancer in women: age, smoking, histology, performance status, stage, initial treatment and survival. Population-based study of 20 561 cases. Ann Oncol 13 (2002), 1087–1093.
11. Torre, L.A., Bray, F., Siegel, R.L., Ferlay, J., Lortet-Tieulent, J., Jamal, A., Global cancer statistics, 2012. CA Cancer J Clin 65 (2015), 87–108.
12. Egleston, B.L., Meireles, S.I., Flieder, D.B., Clapper, M.L., Population-based trends in lung cancer incidence in women. Semin Oncol 36 (2009), 506–515.
13. Weiss, J.M., Lacey, J.V. Jr., Shu, X.O., et al. Menstrual and reproductive factors in association with lung cancer in female lifetime nonsmokers. Am J Epidemiol 168 (2008), 1319–1325.
14. Yao, Y., Gu, X., Zhu, J., Yuan, D., Song, Y., Hormone replacement therapy in females can decrease the risk of lung cancer: a meta-analysis. PLoS One, 8, 2013, e71236.
15. Schabath, M.B., Wu, X., Vassilopoulou-Sellin, R., Vaporciyan, A.A., Spitz, M.R., Hormone replacement therapy and lung cancer risk: a case-control analysis. Clin Cancer Res 10 (2004), 113–123.
16. Clague, J., Reynolds, P., Henderson, K.D., et al. Menopausal hormone therapy and lung cancer-specific mortality following diagnosis: the California Teachers Study. PLoS One, 9, 2014, e103735.
17. Chlebowski, R.T., Anderson, G.L., Manson, J.E., et al. Lung cancer among postmenopausal women treated with estrogen alone in the women's health initiative randomized trial. J Natl Cancer Inst 102 (2010), 1413–1421.
18. Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2012. http://seer.cancer.gov/csr/1975_2012/. Accessed March 20, 2017.
19. Owonikoko, T.K., Ragin, C.C., Belani, C.P., et al. Lung cancer in elderly patients: an analysis of the surveillance, epidemiology, and end results database. J Clin Oncol 25 (2007), 5570–5577.
20. Maggiore, C., Mule, A., Fadda, G., et al. Histological classification of lung cancer. Rays 29 (2004), 353–355.
21. Lou, F., Huang, J., Sima, C.S., Dycoco, J., Rusch, V., Bach, P.B., Patterns of recurrence and second primary lung cancer in early-stage lung cancer survivors followed with routine computed tomography surveillance. J Thorac Cardiovasc Surg 145 (2013), 75–81 [discussion: 81–82].
22. Reinmuth, N., Stumpf, A., Stumpf, P., et al. Characteristics and outcome of patients with second primary lung cancer. Eur Respir J 42 (2012), 1668–1676.
23. Klempner, S.J., Ou, S.-H.I., Costa, D.B., et al. The clinical use of genomic profiling to distinguish intrapulmonary metastases from synchronous primaries in non-small-cell lung cancer: a mini-review. Clin Lung Cancer 16 (2015), 334–339.
24. Govindan, R., Page, N., Morgensztern, D., et al. Changing epidemiology of small-cell lung cancer in the United States over the last 30 years: analysis of the surveillance, epidemiologic, and end results database. J Clin Oncol 24 (2006), 4539–4544.
25. Spratt, D.E., Wu, A.J., Adeseye, V., et al. Recurrence patterns and second primary lung cancers after stereotactic body radiation therapy for early-stage non-small-cell lung cancer: implications for surveillance. Clin Lung Cancer 17:3 (2015), 177–183.
26. Pesch, B., Kendzia, B., Gustavsson, P., et al. Cigarette smoking and lung cancer—relative risk estimates for the major histological types from a pooled analysis of case-control studies. Int J Cancer 131 (2012), 1210–1219.
27. Simonato, L., Agudo, A., Ahrens, W., et al. Lung cancer and cigarette smoking in Europe: an update of risk estimates and an assessment of inter-country heterogeneity. Int J Cancer 91 (2001), 876–887.